Synapse Open Synapse
Biology

STAT+: Mark Cuban wants to crack open the market for rare disease treatments

STAT News · · 1 min read

Mark Cuban's Cost Plus Drugs says it can reduce manufacturing costs for custom rare disease drugs and n-of-1 gene therapies.

Latest from STAT News